Number of QTLs and their effects on plasma HDL levels in familiar combined hyperlipidemia.

被引：0
|
作者：
Gagnon, F [1 ]
Jarvik, GP [1 ]
Motulsky, AG [1 ]
Deeb, SS [1 ]
Brunzell, JD [1 ]
Wijsman, EM [1 ]
机构：
[1] Univ Washington, Dept Med, Seattle, WA USA
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 2000年 / 67卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
1233
引用
收藏
页码：227 / 227
页数：1
相关论文
共 50 条
  • [31] Gender-related association between the -93T→G/D9N haplotype of the lipoprotein lipase gene and elevated lipid levels in familial combined hyperlipidemia.
    Frants, RR
    Bredie, SJH
    Snieder, H
    Reymer, PWA
    Demacker, PNM
    Havekes, LM
    Boomsma, DI
    Stalenhoef, AFH
    Kastelein, JP
    Hoffer, MJV
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A308 - A308
  • [32] A common genetic mechanism determines plasma apolipoprotein B levels and dense LDL subfraction distribution in familial combined hyperlipidemia
    Juo, SHH
    Bredie, SJH
    Kiemeney, LA
    Demacker, PNM
    Stalenhoef, AFH
    AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (02) : 586 - 594
  • [33] Triglyceride/HDLCholesterol (C) levels vs. apo-A1 and apo B in coronary artery disease (CAD) for recognition of familiar combined hyperlipidemia (FCH)
    Abudu, N
    Levinson, S
    Miller, J
    CLINICAL CHEMISTRY, 2003, 49 (06) : A166 - A166
  • [34] Plasma proprotein convertase subtilisin kexin type 9 levels are related to markers of cholesterol synthesis in familial combined hyperlipidemia
    Brouwers, M. C. G. J.
    Konrad, R. J.
    van Himbergen, T. M.
    Isaacs, A.
    Otokozawa, S.
    Troutt, J. S.
    Schaefer, E. J.
    van Greevenbroek, M. M. J.
    Stalenhoef, A. F. H.
    de Graaf, J.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2013, 23 (11) : 1115 - 1121
  • [35] Novel QTLs for HDL levels identified in mice by controlling for Apoa2 allelic effects:: confirmation of a chromosome 6 locus in a congenic strain
    Welch, CL
    Bretschger, S
    Wen, PZ
    Mehrabian, M
    Latib, N
    Fruchart-Najib, J
    Fruchart, JC
    Myrick, C
    Lusis, AJ
    PHYSIOLOGICAL GENOMICS, 2004, 17 (01) : 48 - 59
  • [36] Plasma PAI-1 levels are independently related to fatty liver and hypertriglyceridemia in familial combined hyperlipidemia, involvement of apolipoprotein E
    Brouwers, Martijn C. G. J.
    Govers-Riemslag, Jose
    Schalkwijk, Casper G.
    van Greevenbroek, Marleen M. J.
    van der Kallen, Carla J. H.
    Bekers, Otto
    van Dieijen-Visser, Marja P.
    ten Oever, Jaap
    Bilderbeek-Beckers, Monique A. L.
    de Bruin, Tjerk W. A.
    ten Cate, Hugo
    Stehouwer, Coen D. A.
    THROMBOSIS RESEARCH, 2008, 122 (04) : 466 - 472
  • [37] Lithium and valproate combined administration: Acute behavioural effects and drug plasma levels
    Vargas, C
    Tannhauser, M
    Tannhauser, SL
    Barros, HMT
    PHARMACOLOGY & TOXICOLOGY, 1996, 79 (02): : 87 - 91
  • [38] Increased plasma levels of oxysterols, in vivo markers of oxidative stress, in patients with familial combined hyperlipidemia: Reduction during atorvastatin and fenofibrate therapy
    Arca, Marcello
    Natoli, Silvia
    Micheletta, Fausta
    Riggi, Sara
    Di Angelantonio, Emanuele
    Montali, Anna
    Antonini, Teresa Maria
    Antonini, Roberto
    Diczfalusy, Ulf
    Iuliano, Luigi
    FREE RADICAL BIOLOGY AND MEDICINE, 2007, 42 (05) : 698 - 705
  • [39] Effects of allyl isothiocyanate on the number of white blood cells and plasma corticosterone levels in rats
    Kawashima, Yu
    Sasaki, Hiromi
    Sakakibara, Yuko
    Sato, Shogo
    Ban, Takamasa
    Tanihata, Jun
    Tachiyashiki, Kaoru
    Imaizumi, Kazuhiko
    JOURNAL OF PHYSIOLOGICAL SCIENCES, 2010, 60 : S191 - S191
  • [40] Increased plasma levels of apo B and small dense LDL in familial combined hyperlipidemia are not fully explained by the degree of insulin resistance and/or obesity
    Veerkamp, MJ
    de Graaf, J
    Stalenhoef, AFH
    CIRCULATION, 2002, 106 (19) : 184 - 184
12345